Why the study?
Anthracyclines induce heart failure in lymphoma chemotherapy, and measuring the Tei index could anticipate the onset of LV dysfunction earlier than conventional echocardiographic parameters.
Does serial monitoring of the echocardiographic Tei index (ΔTei index) detect early subclinical cardiac dysfunction earlier than LVEF in lymphoma patients treated with anthracyclines?
Cohort (n=41)
No
Does serial monitoring of the echocardiographic Tei index (ΔTei index) detect early subclinical cardiac dysfunction earlier than LVEF in lymphoma patients treated with anthracyclines?
Echocardiographic Tei index evaluation during anthracycline chemotherapy correlates with compensatory left ventricular volume and stroke volume adaptations before any detectable drop in LVEF, potentially identifying lymphoma patients at higher risk for cardiotoxicity.
Answers are grounded in this paper and cite their sources.
May support early detection of compensatory LV changes; leaves open whether Tei monitoring improves risk stratification in anthracycline-treated lymphoma.
Anthracyclines are widely employed in lymphoma's chemotherapy and has been shown to induce heart failure. Echocardiographic parameters of left ventricular (LV) systolic function are usually used to monitor the cardiac side effects during and after anthracyclines treatment. The measurement of theTei index could anticipate the onset of LV dysfunction. The aim of this study was to evaluate the performance of the delta Tei index for the early detection of cardiac toxicity in a prospective population of anthracycline-treated lymphoma patients. Our preliminary data suggest that the Tei index may predict the risk for cardiotoxicity in this subset of patients earlier than LV ejection fraction alteration.
No takes yet. Share an insight, caveat, or question.
Puzzovivo et al. (2022) conducted a cohort in Hodgkin and non-Hodgkin's lymphoma treated with anthracyclines (n=41). High Tei index change (Tei+) vs low Tei index change (Tei-) during anthracycline chemotherapy vs. Low Tei index change (Tei-) was evaluated on Early cardiotoxicity and correlation of baseline Tei index with LVEF, EDV, and SV at 12 months (p=0.04).
Synapse has enriched 10 related papers. Consider them for comparative context: